TrialX Updates: Supporting Health Research Data Collection for the Historic Ax-4 Space Mission, AI Powered Clinical Trial Finders and More…

In partnership with the Translational Research Institute for Space Health (TRISH), TrialX is supporting the historic Axiom-4 mission by enabling critical health data collection to further our understanding of human health and performance in space.

The Ax-4 mission — Axiom Space’s fourth commercial astronaut flight to the International Space Station launched on June 25th and we’re thrilled to announce that TrialX is once again playing a key role in advancing space health research. In partnership with the Translational Research Institute for Space Health (TRISH), TrialX is supporting this historic mission by enabling critical health data collection to further our understanding of human health and performance in space. The crew will spend about two weeks on the space station and conduct nearly 60 science experiments. Building on our contributions to previous missions like Ax-1 through Ax-3, Fram2, and Inspiration4, we continue pushing the boundaries of decentralized research beyond Earth. Learn more.


What’s New at TrialX! 🚀

📢 PRODUCT UPDATES 

We’re honored to share that TrialX’s global clinical trial finder now powers the ALS Network’s Trial Finder—an AI-driven platform designed to help individuals easily discover clinical trials focused on amyotrophic lateral sclerosis (ALS) and related motor neuron diseases. The new tool offers a personalized, user-friendly search experience—guiding users through tailored questions, smart filters, and clear trial summaries to help them connect with relevant studies and stay informed through a volunteer registry. ALS is a progressive and fatal neuromuscular condition with no known cure, affecting approximately 5.2 people per 100,000 in the U.S. alone. Learn more.


We’re proud to support clinical trial awareness, patient recruitment and engagement efforts for the world’s leading pharmaceutical companies — including powering the clinical trial volunteer registry for a top 3 pharma. Explore how patients are getting connected to trials that matter. 


Our Executive Chairman, Eric Sandor, shared insights on leveraging AI to enhance patient recruitment and engagement at the recently held Patients as Partners Europe 2025 conference in London. As executive sponsors, we were proud to showcase our upcoming innovations in AI-powered recruitment solutions, reaffirming our commitment to advancing patient-centric clinical trials. Learn More.

RECENT CURETALKS 

We had the privilege of talking to Nobel Laureate Dr. Drew Weissman from The University of Pennsylvania, about the expanding potential of mRNA technology. In this insightful conversation, Dr. Weissman shares how the mRNA platform is being explored to treat celiac disease, cancer, HIV, autoimmune disorders, and neurological and cardiovascular conditions—unlocking a future where medicine is more targeted, responsive, and effective. Watch here.

🧬 FEATURED CLINICAL STUDIES 

Powered by TrialX

RISE Above Smoking: Researchers from the University of Pennsylvania are studying how remote versus in-person support impacts success in quitting smoking using nicotine patches and lozenges. The study aims to improve smoking cessation support, particularly for groups experiencing health inequities.


The BURST Study: The Behavior, Understanding, and Relationships During School Transition (BURST) Study, led by researchers at Indiana University, explores how puberty, cognitive development, social relationships, and health behaviors change as children move from elementary to middle school.


CRSwNP Clinical Study: Researchers are studying a potential new treatment, lunsekimig, for adults aged 18–70 with chronic rhinosinusitis with nasal polyps (CRSwNP). This condition causes long-term nasal inflammation, leading to symptoms like nasal congestion, runny nose, and loss of smell. The study will assess whether lunsekimig can reduce symptoms and polyp size in patients whose condition is not well controlled by current treatments.


Light Therapy in PD: Photoreceptor-directed Light Therapy in Parkinson’s Disease, is a Phase II study testing a novel approach that targets sleep-regulating cells in the eye. By using customized lighting to stimulate these cells, researchers aim to improve sleep quality and motor symptoms, with the goal of developing personalized, in-home light therapy for Parkinson’s.


🌎 AROUND THE WEB 

👨‍🚀 Ax-4 crew docks with the ISS: 28 hours between launch and rendezvous.
🤖 AI gets official: The FDA launches a new agency-wide AI tool to boost performance.
🧬 Space vs. cancer: Off-Earth research may hold the key to fighting cancer.
💉 Bold shot: A breakthrough vaccine could eradicate breast cancer by 2030.
✍️ Penning the future: An AI-powered pen detects early Parkinson’s through handwriting.


‼️ NOTEWORTHY 


🤝 TEAM UPDATES  

🥳SONGS FOR THE UNSUNG CLINICAL RESEARCH HEROES 🎶

This World Music Day, we celebrated in the most meaningful way — by launching something close to our hearts.🎵 Songs for the Unsung by TrialX – is a free website where you can create a personalized song to honor someone who makes clinical research possible: a patient, a coordinator, a researcher, a caregiver — an unsung but impactful hero. It takes just a minute, and the result is a musical tribute they’ll never forget. We’d love for you to try it — whether for yourself, your team, or someone who should be recognized. If possible, tag them on Linkedin sharing their song with the world. Please tag us too so we can amplify your voice. Let’s turn appreciation into melody and let clinical research heroes hear how much they matter. 👉 Create your song here.


🧑‍💻️ WE ARE HIRING!

At TrialX, we obsess over outcomes that improve patients’ lives and sponsors’ success. We are hiring a Product Manager – Clinical Trial Recruitment Platform (Enterprise SaaS) for our NY/NJ/PA  office. Email your resume and a short note about how you would elevate AI‑powered patient recruitment and engagement to jobs@trialx.com. Join TrialX and build products that embody excellence and push the boundaries of what’s possible—while learning for life. Learn More.

At TrialX, we strive to revolutionize the way clinical trials are conducted on earth and in space, by focusing on innovative solutions to streamline patient recruitment and remote data collection. Stay tuned for more updates as we continue to look up to the Moon & Mars!

Tags: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , ,
6

Get in touch to learn more about TrialX's Remote Data Collection Solutions

Request a Demo
29158

Shweta Mishra

Shweta is Marketing and Communications Lead at TrialX/Applied Informatics. She is a clinical trials enthusiast and also hosts women's health/infertility/reproductive medicine talk series driven by her personal experiences for TrialX CureTalks. A San Jose State University Graduate, she holds dual masters degree in Biochemistry and Nutrition Science, and is passionate about the science behind the diverse life phenomenon. She also holds certifications in Marketing Management & Strategy, Digital Marketing from Hubspot Academy, Protecting Human Research Participants from NIH and in Intellectual Property in Biotechnology from WIPO.